Bio Pharma Dive

OCTOBER 21, 2024

What else does the research tell us? Immunotherapy and precision medicine show promise in better fighting cancer.

Research 264

Research Medicine 264

Bio Pharma Dive

JANUARY 10, 2022

Pfizer's work with mRNA vaccines led it explore other applications of the technology, resulting in a multi-year partnership with the high-profile biotech Beam Therapeutics on gene editing treatments for rare diseases.

Gene Editing 363

Gene Editing Gene Research Vaccine 363

Bio Pharma Dive

NOVEMBER 16, 2022

Tricida, Harpoon, Freeline and three other small drug developers have this week announced plans to cut staff or to reprioritize their drug development.

Research 347

Research Development Drugs 347

Bio Pharma Dive

OCTOBER 6, 2023

The funding, which is part of ACT for ALS, will support expanded access studies of drugs developed by Prilenia Therapeutics, Clene Nanomedicine and Rapa Therapeutics.

Drugs 321

Drugs Research Development 321

Bio Pharma Dive

JANUARY 30, 2023

The report, a yearly poll of 100 financing executives by accounting and consulting firm BDO, revealed the many levers young drugmakers are pulling to conserve cash.

Research 341

Research 341

Bio Pharma Dive

APRIL 20, 2023

The company, which previously raised $32 million in Series A funding, joins a growing list of new startups working to develop targeted radiation treatments.

Research 309

Research Development 309

Bio Pharma Dive

SEPTEMBER 3, 2024

While results from two after-the-fact analyses were “reassuring,” outside experts urged “continued vigilance” to ensure GLP-1 drugs don’t worsen problems in people with preexisting mental health conditions.

Drugs 312

Drugs Research 312

Rethinking Clinical Trials

JANUARY 8, 2024

The post January 8, 2024: Pragmatic Trials Researchers Share Lessons From Collecting Patient-Reported Outcomes in the Electronic Health Record appeared first on Rethinking Clinical Trials. This work was a collaboration between the Electronic Health Records Core and the Patient-Centered Outcomes Core of the NIH Pragmatic Trials Collaboratory.

Trials 298

Trials Clinical Trials Clinical Trials Research 298

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 22, 2024

The Indian Council of Medical Research (ICMR) has announced a Request for Expressions of Interest (EoI) aimed at inviting researchers, academicians, and scientists to participate in the formulation of evidence-based guidelines for the empirical use of antibiotics in the management of sepsis, dental infections, and vaginal discharge.

Research 192

Research Development Scientist Clinical Trials 192

Bio Pharma Dive

APRIL 22, 2024

A collaboration with BioArctic will focus on a technology designed to more effectively deliver drugs in the brain, following similar efforts by Roche.

Drugs 295

Drugs Research 295

Pharmaceutical Technology

JANUARY 3, 2024

A new report from Novotech delves into the multifaceted landscape of HIV, focusing on its impact, treatment, and global initiatives.

Clinical Trials 295

Clinical Trials Clinical Trials Trials Research 295

Bio Pharma Dive

SEPTEMBER 6, 2023

Jane Grogan, an industry veteran who worked at Genentech for over 15 years, will take over the role starting Oct. She’ll fill a seat that's lacked a permanent replacement since the departure of Al Sandrock.

Research 310

Research 310

Bio Pharma Dive

OCTOBER 11, 2022

Launched last year to change how drugs for brain diseases are made, the biotech has now raised about $650 million to build a pipeline that includes two clinical-stage medicines.

Research 331

Research Medicine Drugs 331

Bio Pharma Dive

JULY 9, 2024

The company has begun searching for a successor to Dolsten, who oversaw more than 35 drug and vaccine approvals but also some notable setbacks during his time as Pfizer’s top scientist.

Scientist 312

Scientist Research Vaccine Vaccination 312

Worldwide Clinical Trials

OCTOBER 29, 2024

By: Juliane Mills, Senior Director, Therapeutic Strategy Lead, Rare Disease The rise of patient-led clinical research, particularly in rare disease, represents a significant shift in the clinical trial landscape. Why Is There an Increase in Patient-Led Rare Disease Research?

Clinical Research 182

Clinical Research Research Clinical Trials Clinical Trials 182

Bio Pharma Dive

MARCH 21, 2024

The job cuts at the cancer drug developer will primarily impact manufacturing roles, but will touch on several other parts of the organization, the company said.

Research 298

Research Manufacturing Development Drugs 298

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 30, 2024

Researchers see a greater need for new generation therapeutics to propel precision medicine. The current research areas of interest in India include precision medicine which treatments based on individual genetic profiles to improve […]

Medicine 167

Medicine Research Gene Therapy Genetics 167

Bio Pharma Dive

MAY 21, 2024

Since pivoting from oncology, the startup has raised close to $300 million and advanced an ulcerative colitis drug into mid-stage testing.

Drugs 290

Drugs Research 290

Bio Pharma Dive

JANUARY 6, 2023

The cuts at Fate, Century Therapeutics and TCR2 Therapeutics signal a longer road in the companies’ plans to develop next-generation cell therapies for cancer.

Research 317

Research Development 317

Bio Pharma Dive

JUNE 2, 2022

Backed by $200 million in funding and led by biotech veteran Samantha Truex, Upstream is developing a clinical-stage inflammatory disease drug acquired from Astellas last year.

Drugs 339

Drugs Research Development 339

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 18, 2024

Click here Research + Font Resize – ICMR to hold workshop on measuring oxidative stress in pre-clinical mouse models to boost […] Home Editorial Services Interview Q&A Chronicle Specials Pharma Mart ePharmail Archives Join Pharma | Login Home > TopNews you can get e-magazine links on WhatsApp.

Clinical Research 199

Clinical Research Research Clinical Trials Clinical Trials 199

Bio Pharma Dive

NOVEMBER 20, 2024

Negative results from a Huntington’s trial add to a calamitous year for Sage, which last month decided to overhaul its research, reconfigure its executive team and lay off a third of its staff.

Research 162

Research Trials 162

Bio Pharma Dive

DECEMBER 12, 2023

Just before clearing Pfizer’s buyout of Seagen, the regulator threatened to block Sanofi’s licensing deal with Maze Therapeutics, a challenge the biotech called ‘‘unprecedented.”

Licensing 309

Licensing Licensing Regulation Research 309

Bio Pharma Dive

OCTOBER 27, 2023

In a wide-ranging interview, Bristol Myers’ Ken Rhodes talked biomarkers, diseases of interest and why the company is far from done with neuroscience-focused deals.

Research 316

Research Drugs 316

Pharmaceutical Technology

JULY 3, 2024

Academic institutions and nonprofit organisations are jumping in to save access to complex gene therapies.

Gene Therapy 246

Gene Therapy Gene Research 246

Bio Pharma Dive

OCTOBER 19, 2023

The base editing specialist will prioritize medicines for sickle cell and alpha-1 antitrypsin deficiency, while trimming its plans for other programs in cancer and hepatitis B.

Research 290

Research Medicine 290

Rethinking Clinical Trials

OCTOBER 3, 2024

Platt is a cochair of the NIH Collaboratory’s Distributed Research Network and the Harvard Pilgrim Health Care Institute Distinguished Professor of Population Medicine at the Harvard Pilgrim Health Care Institute and Harvard Medical School. View the full workshop materials.

Clinical Trials 195

Clinical Trials Clinical Trials Research Trials 195

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 12, 2024

The Indian Council of Medical Research (ICMR) has issued a call for proposals for its Centre for Advanced Research (CAR) initiative under the Extramural Research Programme, inviting experienced research teams to apply for funding aimed at advancing healthcare research in critical areas.

Research 152

Research Clinical Trials Clinical Trials Trials 152

Bio Pharma Dive

MARCH 1, 2024

Reeling from a difficult year financially, the pharma unveiled a new oncology division it says will produce eight billion-dollar medicines by 2030.

Research 238

Research Medicine Drugs 238

Bio Pharma Dive

OCTOBER 30, 2023

PrwS studies can reach beyond the limitations of today’s RWE studies and expand the role of RWD across the entire drug development cycle.

Clinical Research 279

Clinical Research Research Development Drugs 279

Rethinking Clinical Trials

DECEMBER 3, 2024

In a new report from the NIH Pragmatic Trials Collaboratory, a team of bioethicists explores the ethical obligation to share aggregate results from pragmatic clinical trials with research participants. There is growing appreciation of the importance of sharing aggregate results of clinical trials with research participants.

Trials 124

Trials Clinical Trials Clinical Trials Research 124

Worldwide Clinical Trials

OCTOBER 14, 2024

Fortunately, advances in clinical research are providing hope for better treatments and outcomes. With the support of global networks like ours at Worldwide Clinical Trials (Worldwide), autoimmune and bone health research is accelerating, providing new solutions to patients around the world.

Research 147

Research Clinical Trials Clinical Trials Immune Response 147